Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis
Nikolaj Frost, Kristina Unger, Torsten Blum, Daniel Misch, S Kurz, H Lüders, Elisabeth Olive, Matthias Raspe, Moritz Hilbrandt, Myriam Koch, Dirk Böhmer, Carolin Senger, Martin Witzenrath, Christian Grohé, Torsten Bauer, Dominik Paul Modest, Jens Kollmeier
Topics & Concepts
MedicinePneumonitisInternal medicineLung cancerAdverse effectHazard ratioRetrospective cohort studyRadiation therapyOdds ratioGastroenterologyCancerLungConfidence intervalCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Treatments and Mutations